Company Profile | February 28, 2014

2014 CRO Leadership Awards Winner

icon logo

Categories Won:

  1. Quality

  2. Reliability

  3. Productivity

  4. Innovation

 

Drug Life Cycle Stages:
Research & Development: Discovery, Preclinical, Clinical (Phase 1, Phase 2, Phase 3)

Main Service Areas:
Bioanalytical, Clinical, Preclinical

Services & Capabilities:
Clinical pharmacology, bioanalytical labs, clinical pathology, protocol design, biomarkers, pharmacodynamic/pharmacokinetic analysis, data management, medical and safety services, biostatistics, interactive technologies, patient recruitment, medical imaging, central laboratory services, medical writing, resourcing, health economics & outcomes research, pricing & market access

Therapeutic Areas:
Cardiology/vascular diseases, endocrinology, gastroenterology, genetic disease, hematology, hepatology (liver, pancreatic, gall bladder), immunology, infections and infectious diseases, musculoskeletal, nephrology, neurology, oncology, ophthalmology, orthopedics, pharmacology, psychiatry/psychology, pulmonary/respiratory diseases, rheumatology, urology, vaccines

Tom O'Leary

chief information officer

“We are delighted to be recognized by the industry for reliability and innovation. To us, innovation is not an option — it is a priority if we are to continue to help our customers achieve greater levels of efficiency and performance in clinical study delivery. This relentless pursuit of improvement is what distinguishes ICON as a trusted and reliable partner for our customers. We remain committed to driving innovation through leveraging the creativity, experience, and passion of ICON employees.”